On February 3, 2026, the Brazilian Health Regulatory Agency (Anvisa) published five resolutions establishing a new regulatory framework for the cultivation of cannabis for medical, pharmaceutical, and research purposes in Brazil. The resolutions were approved at the Anvisa collegiate board’s first public meeting of 2026, and come in the wake of a November 2024 decision at the Superior Court of Justice (STJ) that gave Anvisa the obligation and authority to regulate medical cannabis planting and cultivation, as well as subsequent stages of the production chain.